Publication
Fentanyl Signature Profiling Program Report
October 28, 2019
|
Intelligence
Download Document
The Fentanyl Signature Profiling Program (FSPP) performs in-depth chemical analyses on fentanyl and fentanyl-related exhibits obtained from seizures made throughout the United States. This report details the results and conclusions derived from these analyses that are reported on a quarterly basis. FSPP data is not intended to reflect U.S. market share, but is rather a snapshot of samples submitted to this laboratory from the 7 DEA regional laboratories.
Attachments
DEA_Fentanyl_Signature_Profiling_Program_Report-Oct-2019.pdf